Virtual Reality in Hand Peripheral Nerve Injuries Effectiveness of Based Movement Therapy

Sponsor
Kocaeli University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05898568
Collaborator
(none)
46
1
2
6
7.7

Study Details

Study Description

Brief Summary

The aim of this study is to investigate the effectiveness of virtual reality-based motion therapy in peripheral nerve injuries in the hand.

Condition or Disease Intervention/Treatment Phase
  • Device: virtual reality
  • Behavioral: routine treatment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Virtual Reality in Hand Peripheral Nerve Injuries Effectiveness of Based Movement Therapy
Actual Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: experimental: virtual reality

In addition to routine hand care programs for 4 weeks, 5 days, 40 minutes a day, 20 sessions (4 weeks, 5 days, 20 minutes) virtual reality based movement therapy program will be applied.

Device: virtual reality
In addition to the routine hand rehabilitation programs for 4 weeks, 5 days, 40 minutes a day, 20 sessions (4 weeks, 5 days a week, 20 minutes) virtual reality based movement therapy program will be applied.

Active Comparator: control:routine treatment

20 sessions (4 weeks, 5 days a week, 60 minutes) routine hand rehabilitation program will be implemented.

Behavioral: routine treatment
20 sessions (4 weeks, 5 days a week, 60 minutes) routine hand rehabilitation program will be applied.

Outcome Measures

Primary Outcome Measures

  1. Jebsen Taylor Hand Function Test [from baseline to the end of the treatment (4 week)]

    Used to assess upper extremity functions. Activities are evaluated on a time basis.

  2. visual analog scale (VAS) [from baseline to the end of the treatment (4 week)]

    marks the severity of pain between 0 and 10.

  3. duruöz hand index [from baseline to the end of the treatment (4 week)]

    kitchen work, evaluates cleaning, workplace and other activities of daily living. The total score is between 0-90.

  4. Sammes Weinstein Monofilament Test (SWMT) [from baseline to the end of the treatment (4 week)]

    sensory threshold is used for assessment.sensed monofilament values will be collected and recorded. The highest total score will be considered as 15.

  5. Questionnaire Quick Disability of the Arm, Shoulder, and Hand (Quick DASH) [from baseline to the end of the treatment (4 week)]

    activity participation level will be assessed by Q-DASH.Each question will be scored between 1-5 points (1: no difficulty, 2: mild difficulty, 3: medium difficulty, 4: extreme difficulty, 5: not at all). The total score will be recorded.

  6. Jamar dynamometer [from baseline to the end of the treatment (4 week)]

    Jamar dynamometer will be used for grip strength. 3 repetitive measurements will be made and the average will be recorded.(in kilograms)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ıt was operated in the early period with the diagnosis of peripheral nerve injury in the postoperative hand.

  • clinical impression was made.

  • out patient with median, ulnar, and radial nerve repair.

  • completed the 6th postoperative week.

Exclusion Criteria:
  • Those who have communication problems and users

  • With the musculoskeletal system, the additional passage, rheumatological, etc., where they are located.

those with the disease

  • Patients with multiple traumas

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kocaeli University Kocaeli Arızlı Turkey 41100

Sponsors and Collaborators

  • Kocaeli University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Serkan Kablanoğlu, occupational therapist, Kocaeli University
ClinicalTrials.gov Identifier:
NCT05898568
Other Study ID Numbers:
  • E-66175679-514.13.02-960185
First Posted:
Jun 12, 2023
Last Update Posted:
Jun 12, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 12, 2023